EXTR:NASDAQExtreme Networks, Inc. Analysis
Data as of 2026-04-01 - not real-time
$15.20
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Extreme Networks posted a solid 13.8% year‑over‑year revenue increase and a strong 61% gross margin, while operating margins sit at 6.4% and profit margins, though thin, are positive at 0.75%. Forward earnings expectations are compelling – the forward P/E has collapsed to about 12× versus a trailing P/E of 253×, and a discounted cash‑flow model suggests a fair value near $25.55, implying roughly 54% upside from the current $15.20 price. The company also reported a 25.2% jump in SaaS ARR and secured a $95.2 million shelf registration, underscoring its growth‑focused strategy. Technical indicators are mixed: price is trading above the 20‑day (14.82) and 50‑day (14.67) SMAs but below the 200‑day SMA (17.73), the MACD is bullish, and RSI sits at 56, indicating no extreme overbought/oversold condition. Support sits around $13.54 with resistance near $15.68, and the stock has been volatile (≈25% 30‑day volatility) and beta‑rich (≈1.44), suggesting heightened sensitivity to market moves. Overall, the valuation gap, growth in recurring SaaS revenue, and net‑cash position provide a compelling case for upside, while elevated volatility and a high debt‑to‑equity ratio warrant cautious positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram and price above short‑term SMAs
- Proximity to near‑term resistance at $15.68
- Elevated volatility and beta increasing short‑term price swings
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 13.8% revenue growth and 25% SaaS ARR expansion
- Forward P/E ~12× and DCF implied upside >50%
- New $95.2M shelf registration funding growth initiatives
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic positioning in AI‑powered networking and cloud management
- Net‑cash balance (cash exceeds debt) providing financial flexibility
- Long‑term valuation disparity with fair value suggesting substantial upside
Key Metrics & Analysis
Financial Health
Revenue Growth13.80%
Profit Margin0.75%
P/E Ratio253.3
ROE12.43%
ROA3.38%
Debt/Equity221.16
P/B Ratio21.3
Op. Cash Flow$148.1M
Free Cash Flow$142.1M
Industry P/E33.2
Technical Analysis
TrendNeutral
RSI56.2
Support$13.54
Resistance$15.68
MA 20$14.82
MA 50$14.67
MA 200$17.73
MACDBullish
VolumeStable
Fear & Greed Index77.61
Valuation
Fair Value$25.55
Target Price$23.38
Upside/Downside53.78%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.44
Volatility24.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.